Journal profile · Medicine-Immunology and Allergy
Journal of Allergy and Clinical Immunology Global
ISSN 2772-8293 · Elsevier · United States
Journal of Allergy and Clinical Immunology Global: impact factor 2.6 (journal website); fully open access; APC about USD 2,000; median 115 days to acceptance (95 articles, last 24 months); acceptance rate 71% (journal website); 226 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Allergy and Clinical Immunology Global is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research and Allergic Rhinitis and Sensitization, together about 40.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JACI: Global is a peer-reviewed, open access, online publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), which started publishing in 2021. It joins the other members of the AAAAI family of journals - The Journal of Allergy and Clinical Immunology (JACI) and JACI: In Practice, respectively two of the most highly-cited allergy and clinical immunology journals (2023 Journal Citation Reports, published by Clarivate Analytics).Mission The overall mission of JACI: Global is to provide authors with a fully Open Access journal for allergy/immunology-relevant work that includes global and regional perspectives, with no barrier to access for anyone with an internet connection.Scope As the AAAAI's Open Access journal, JACI: Global publishes reports describing original research - basic, translational and clinical - related to all aspects of allergy, immunology, and related fields. This very broad scope mirrors the scope of its two companion journals. In addition to translational content, JACI: Global publishes basic science, Phase I/II clinical trials, population studies, as well as regionally relevant research relating to allergy and immunology.JACI: Global provides a (high-)quality outlet for authors whose funders require them to publish in a Gold Open Access journal. One of the journal's hallmarks is its geographic diversity, with an emphasis on global and regional research and practice. This makes the journal particularly appealing to authors working in Research4Life countries, with waivers or deep discounts of accepted Article Processing Charges (APCs) automatically provided by our publisher, Elsevier. JACI: Global also provides an important service to the growing number of funders who have joined Plan S (the European cOAlition S initiative) that requires full Open Access of research funded by its members, including the Gates Foundation, the Wellcome Trust, UK Research and Innovation, and the World Health Organization (see https://www.coalition-s.org).Content All JACI: Global content is peer-reviewed. Content flows to JACI: Global from three primary sources:Authors may submit directly to JACI: Global.The Editors-in-Chief of JACI and JACI: In Practice may recommend that authors, whose papers are not suitable for acceptance in these journals, to consider submitting to JACI: Global which has a broader scope and includes developmental and early stage research, as well as informative case reports. This provides a valued service to authors which may expedite publication of their research.The Editors of JACI: Global may invite submissions of articles.In order to facilitate the transfer of papers which are of sound science but not accepted by JACI or JACI: In Practice, JACI: Global uses the same article types as JACI.NoticePractitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher or the American Academy of Allergy, Asthma & Immunology for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Immunology and Allergy
Editor-in-chief David B. PedenPublisher website
Editorial board by country: none in mainland China; most named United States 10, Italy 4, Brazil 3, United Kingdom 2, Japan 1 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine17.4%
- Food Allergy and Anaphylaxis ResearchMedicine13.9%
- Allergic Rhinitis and SensitizationMedicine9.2%
- Drug-Induced Adverse ReactionsMedicine6.5%
- Dermatology and Skin DiseasesMedicine5.8%
- Eosinophilic EsophagitisMedicine4.8%
- Urticaria and Related ConditionsMedicine3.8%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.6Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- CiteScore (publisher)
- 3.3Publisher website ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 0.87LetPub ·
- h-index
- 20OpenAlex ·
- i10-index
- 66OpenAlex ·
- 2-year mean citedness
- 1.96OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 195LetPub ·
Articles by year OpenAlex count · 758 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 141 | 141 | 29 |
| 2025 | 226 | 226 | 317 |
| 2024 | 185 | 185 | 737 |
| 2023 | 124 | 124 | 830 |
| 2022 | 77 | 77 | 625 |
| 2021 | 5 | 5 | 53 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 88 days – 157 days
- Acceptance to online
- median 60 days (95 articles)
- Submission to online
- median 171 days
- Sample
- 95 articles with submission and acceptance dates (439 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Acceptance rate (publisher)
- 71%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 129 daysPublisher website ·
- Submission to publication (journal-reported)
- about 27 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,000 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,500 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
Article types accepted10, with length limits
- brief reports deposited in the online repository. A brief report is 1,500 words long, has a maximum of five display items (figures and/or tmain text ≤ 1,500 words · abstract ≤ 250 words · references ≤ 25
- case reportreview. A Case Report must: Be brief. A Case Report should not exceed 1,000 words, not including the figure legend(s) and references. The figmain text ≤ 1,000 words
- case reportsF. Case reports: Case reports focused on novel or difficult cases or descriptions of regional practices will be of particular interest in the Journal. Case Repo…Length not stated
- correspondenceC. JACI: Global accepts two kinds of Correspondence: a. Correspondence related to papers published in JACI: Global, and b. Correspondence which is NOT related t…main text ≤ 500 words
- original articleThe JACI: Global will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasi…main text ≤ 3,500 words
- original articlesA. Original articles. These articles should describe fully, but as concisely as feasible, the results of original clinical research. Original Articles should no…Length not stated
- reviewThe JACI: Global will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasi…Length not stated
- review articleD. Review articles published in the Journal are invited by the Editors. Proposals for review articles may be emailed to the Editorial Office (JACIGlobal@aaaai.o…main text ≤ 1,000 words · figures and tables ≤ 2 · references ≤ 9
- review articlesD. Review articles published in the Journal are invited by the Editors. Proposals for review articles may be emailed to the Editorial Office (JACIGlobal@aaaai.o…Length not stated
- rostrum articlesE. Opinion articles about subjects of particular interest and/or debate may be accepted for peer review after preliminary review by the Editor. Proposals for ro…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
All authors must disclose all financial relationships for themselves and their immediate family/significant others. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work and any commercial associations that might pose a conflict of interest. These include consultant arrangements, speakers' bureau participation, stock or …
Source ↗Publisher website ·- Data availability Data sharing author instructions statement
Data sharing Model summary
JACI: Global supports data sharing. Authors are encouraged to archive data in an appropriate public repository. Authors may provide a data availability statement with their submission, including a link to the repository they have used, to be published in their article. This statement should be included on the title page of the manuscript. Anyone using these shared data should cite the original pub…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open Access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review process
Single anonymized review process Model summary
JACI: Global operates a single anonymized review process. All contributions will be initially assessed by the Editor-in-Chief for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. Th…
Source ↗Publisher website ·- Plagiarism
Crossref Similarity Check Model summary
To verify compliance, your article may be checked by Crossref Similarity Check and other originality or duplicate checking software.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·- Trial registration / reporting guidelines PRISMA guidelines for systematic reviews and meta-analyses
For meta-analysis of RCTs, we encourage authors to consult the recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement, available at www.prisma-statement.org.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United States
- Language
- English
- ISSN
- 2772-8293
- Society / sponsor
- American Academy of Allergy
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Allergy and Clinical Immunology Global
What is the impact factor of Journal of Allergy and Clinical Immunology Global?
The journal's website gives an impact factor of 2.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.3, h-index 20.
How long does peer review take at Journal of Allergy and Clinical Immunology Global?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 88–157 days); authors report an average review time of about 11 weeks; the journal's website gives an acceptance rate of 71%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Allergy and Clinical Immunology Global?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,500 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Allergy and Clinical Immunology Global based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (10), Italy (4) and Brazil (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Allergy and Clinical Immunology Global?
According to LetPub and DOAJ records, Journal of Allergy and Clinical Immunology Global is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Journal of Allergy and Clinical Immunology Global open access, and what is the APC?
Journal of Allergy and Clinical Immunology Global is a fully open-access journal. APC about USD 2,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .